Innate lymphoid cells prevent graft-versus-host disease via IL-9–driven T-cell senescence
- 27 November 2025
- journal article
- Published by American Society of Hematology in Blood
- Vol. 146 (22) , 2656-2669
Abstract
Innate lymphoid cells (ILCs) are tissue-resident lymphocytes that regulate tissue homeostasis and immune responses. How ILCs modulate T cells, remains incompletely understood. To investigate the interaction between ILCs and T cells, we differentiated ILC2s and ILC3s from hematopoietic stem cells (HSCs). Both suppressed T-cell proliferation, enhanced cytokine production, and upregulated T-cell senescence–associated surface receptors (CD57, KLRG1, TIGIT, and TIM3). T cells exposed to ILCs also increased expression of senescence-related proteins, including p16, p21, p53, GATA4, and NF-κB. Mechanistically, ILCs produced interleukin-9 (IL-9), and IL-9 blockade prevented ILC-driven T-cell senescence. Conversely, addition of exogenous IL-9 to T cells recapitulated the effects of ILC coculture. Finally, in both human xenogeneic and murine allogeneic hematopoietic cell transplantation models, we observed ILC-mediated T-cell modulation in vivo, with evidence of T-cell senescence. In conclusion, HSC-derived ILCs from both humans and mice mitigate graft-versus-host disease by inducing T-cell senescence.Keywords
This publication has 46 references indexed in Scilit:
- OMIP‐086: Full spectrum flow cytometry for high‐dimensional immunophenotyping of mouse innate lymphoid cellsCytometry Part A, 2022
- IL‐4/IL‐13‐producing ILC2s are required for timely control of intestinal helminth infection in miceEuropean Journal of Immunology, 2022
- Protocols for Studying Murine ILC Development2020
- Developmental options and functional plasticity of innate lymphoid cellsCurrent Opinion in Immunology, 2017
- Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter StudyTransplantation and Cellular Therapy, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 ResponsesCell, 2015
- Mesenchymal stem cell therapy and acute graft-versus-host disease: a reviewHuman Cell, 2014
- Senescence Regulation by the p53 Protein Family2012
- Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II StudyTransplantation and Cellular Therapy, 2009